Polymyositis with cytochrome oxidase negative muscle fibres - Early quadriceps weakness and poor response to immunosuppressive therapy

被引:68
作者
Blume, G
Pestronk, A
Frank, B
Johns, DR
机构
[1] WASHINGTON UNIV, SCH MED, DEPT NEUROL, ST LOUIS, MO 63110 USA
[2] WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA
[3] HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA
关键词
muscle; polymyositis; mitochondria; cytochrome oxidase; autoimmune;
D O I
10.1093/brain/120.1.39
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We evaluated 10 patients with histologically typical polymyositis except for an excess of muscle fibres with absent cytochrome oxidase (COX) staining. No biopsies had vacuoles or congophilic material in muscle fibres. All patients presented with a history of slowly progressive weakness. The average age of onset was 9 years older than a group of polymyositis patients with normal COX staining of muscle fibres. Selective weakness of knee extension was a prominent and disabling feature in most patients. Serum creatine kinase was usually mildly elevated (363+/-115 U/l) but at levels lower than those in other patients with polymyositis. Mitochondrial DNA analysis showed multiple deletions in 90% of muscles from patients with excessive numbers of COX-negative muscle fibres, a prevalence significantly greater than the 22% figure for controls (P = 0.005). As a group, the patients responded poorly to immunosuppressive therapy. We conclude that patients with polymyositis and an excess of COX-negative muscle fibres, but no inclusion bodies, have common features including selective quadriceps weakness, mitochondrial pathology by histochemical and DNA analysis and a poor response to immunosuppressive therapy. Some of these features are shared with inclusion body myositis (IBM) and this entity cannot be entirely excluded as vacuoles may not be present in all muscle tissue in IBM patients. Evaluation of the COX activity in muscle fibres of patients with inflammatory myopathies provides useful prognostic information regarding the likelihood of improved strength after immunosuppressive treatment.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 33 条
[11]   PREFERENTIAL AMPLIFICATION AND MOLECULAR CHARACTERIZATION OF JUNCTION SEQUENCES OF A PATHOGENETIC DELETION IN HUMAN MITOCHONDRIAL-DNA [J].
JOHNS, DR ;
HURKO, O .
GENOMICS, 1989, 5 (03) :623-628
[12]   DIRECTLY REPEATED SEQUENCES ASSOCIATED WITH PATHOGENIC MITOCHONDRIAL-DNA DELETIONS [J].
JOHNS, DR ;
RUTLEDGE, SL ;
STINE, OC ;
HURKO, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :8059-8062
[13]   LATE-ONSET MITOCHONDRIAL MYOPATHY [J].
JOHNSTON, W ;
KARPATI, G ;
CARPENTER, S ;
ARNOLD, D ;
SHOUBRIDGE, EA .
ANNALS OF NEUROLOGY, 1995, 37 (01) :16-23
[14]  
JOHNSTON W, 1995, ANN NEUROL, V37, P3
[15]  
JOHNSTON W, 1995, ANN NEUROL, V38, P273
[16]   DIFFERENTIAL ACCUMULATIONS OF 4,977 BP DELETION IN MITOCHONDRIAL-DNA OF VARIOUS TISSUES IN HUMAN AGING [J].
LEE, HC ;
PANG, CY ;
HSU, HS ;
WEI, YH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1226 (01) :37-43
[17]  
MIKOL J, 1994, MYOLOGY, P1384
[18]  
MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
[19]   MITOCHONDRIAL-DNA DELETIONS IN INHERITED RECURRENT MYOGLOBINURIA [J].
OHNO, K ;
TANAKA, M ;
SAHASHI, K ;
IBI, T ;
SATO, W ;
YAMAMOTO, T ;
TAKAHASHI, A ;
OZAWA, T .
ANNALS OF NEUROLOGY, 1991, 29 (04) :364-369
[20]   MITOCHONDRIAL-DNA DELETIONS IN INCLUSION BODY MYOSITIS [J].
OLDFORS, A ;
LARSSON, NG ;
LINDBERG, C ;
HOLME, E .
BRAIN, 1993, 116 :325-336